Stribild (Elvitegravir/Cobicistat/FTC/Tenofovir)

The Latest

An Overview of Stribild (Elvitegravir/Cobicistat/FTC/Tenofovir)

Brand Name: Stribild Other Names: EVG/COBI/FTC/TDF, QUAD Drug Class: Combination Drugs

By AIDSinfo

Stribild (Elvitegravir + Cobicistat + Emtricitabine + Tenofovir)

Table of Contents

What Is Stribild? Who Should Take Stribild? What About Drug Resistance? How Is Stribild Taken? What Are the Side Effects? Warnings How Does Stribild React With Other Drugs?

What Is Stribild?

Stribild is a tablet that ...

By AIDS InfoNet

Adherence and HIV Resistance Risk With Stribild

Is HIV resistance something you have to worry about? With antiretrovirals being stronger than ever and keeping people living with HIV (PLWHA) living longer than ever, resistance is a topic that worries a lot of people. We know meds are effective -- a...

By Mathew Rodriguez

Lifting the Brain Fog After 1 Month on Stribild

After only a month on Stribild, one community member shares his thoughts on the medication and why he may need to switch.

By Brad Dalton

One-a-Day HIV Treatments: How Do They Compare? (Infographic)

Just one pill a day to control HIV? This once-fanciful idea became a reality in 2006, when Atripla was approved as the first single-tablet HIV medication regimen in the U.S. A single-tablet regimen (STR) contains meds from different drug classes and ...

Two New HIV Drugs Win Recommendation as Official First-Line Treatment Options

Stribild, a once-daily, single-pill regimen, and Tivicay, a recently approved integrase inhibitor, are now officially on the list of "preferred" HIV medications in official U.S. HIV treatment guidelines.

By Myles Helfand

Day 79: My HIV Viral Load (Video)

This video blog is part of the series "My HIV Journey: Videos of My First Months on HIV Meds, and Where I Am Now." Check out a full list of entries in the series.

As most of you know, I am enrolled in a drug trial measuring Atripla against the "Quad...

By Aaron Laxton

Stribild Gets FDA Approval as New Single-Tablet Regimen

Stribild (formerly known as the Quad), a complete once-daily single-tablet regimen (STR), was approved by the FDA in August. Stribild joins Atripla and Complera as a complete HIV regimen in one pill, each taken once daily.

The FDA based approval on ...

By Enid Vazquez for Positively Aware

The "Quad"

Brand name: Not yet established

Generic name: elvitegravir/cobicistat/emtricitabine/tenofovir, or EVG/COBI/FTC/TDF

Class: Boosted integrase inhibitor and NRTI -- single-tablet regimen (STR)

Manufacturer: Gilead Sciences,, (800) GILE...

By Positively Aware

Four-in-One HIV Pill Enters Late-Stage Clinical Testing

"Gilead Sciences Inc. said Monday it started late stage clinical testing of its four-in-one 'Quad' HIV tablet," the Associated Press reports. The pill includes the drugs elvitegravir, cobicistat, and the two components of Truvada, emtricitabine and t...

By Henry J. Kaiser Family Foundation